Can you provide the average price target for CLARIVATE PLC stock?
13 analysts have analysed CLVT and the average price target is 4.42 USD. This implies a price increase of 74.11% is expected in the next year compared to the current price of 2.54.
NYSE:CLVT • JE00BJJN4441
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CLARIVATE PLC (CLVT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-25 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-25 | Barclays | Maintains | Underweight -> Underweight |
| 2026-01-08 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-12-17 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2025-09-03 | Wolfe Research | Initiate | Peer Perform |
| 2025-07-18 | Jefferies | Downgrade | Buy -> Hold |
| 2025-02-20 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-11-07 | Barclays | Maintains | Underweight -> Underweight |
| 2024-11-06 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-07 | Barclays | Maintains | Underweight -> Underweight |
| 2024-05-09 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-02-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-02-28 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-02-28 | Barclays | Maintains | Underweight -> Underweight |
| 2024-02-28 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-01-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-12-15 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2023-10-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-09-26 | Citigroup | Maintains | Neutral -> Neutral |
| 2023-09-08 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2023-08-25 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2023-08-07 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.629B -1.17% | 2.557B -2.74% | 2.455B -3.97% | 2.401B -2.21% | 2.452B 2.12% | 2.52B 2.77% | 2.653B 5.28% | 2.73B 2.90% | 2.81B 2.93% | 2.892B 2.92% | 2.976B 2.90% | |
| EBITDA YoY % growth | 991.2M 2.97% | 979.1M -1.22% | 951.8M -2.79% | 1.022B 7.38% | 1.045B 2.25% | 1.089B 4.21% | 1.09B 0.09% | 1.123B 3.03% | 1.156B 2.94% | 1.19B 2.94% | 1.225B 2.94% | |
| EBIT YoY % growth | 282.9M 12.22% | 252.1M -10.89% | 194.6M -22.81% | 156.43M -19.61% | 188.94M 20.78% | 240.38M 27.23% | 428.5M 78.26% | 481.85M 12.45% | 533.97M 10.82% | 584.87M 9.53% | 634.64M 8.51% | |
| Operating Margin | 10.76% | 9.86% | 7.93% | 6.52% | 7.71% | 9.54% | 16.15% | 17.65% | 19.00% | 20.22% | 21.33% | |
| EPS YoY % growth | 0.83 -2.35% | 0.74 -10.84% | 0.70 -5.41% | 0.73 3.57% | 0.80 10.21% | 0.98 23.05% | 0.72 -26.35% | 0.75 4.23% | 0.79 4.05% | 0.83 5.19% | 0.86 3.70% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.15 5.48% | 0.19 6.60% | 0.18 -1.52% | 0.19 -7.11% | 0.17 13.97% | 0.21 8.98% | 0.20 15.09% | 0.21 12.55% |
| Revenue Q2Q % growth | 579.57M -2.38% | 606.64M -2.38% | 618.18M -0.79% | 598.09M -3.06% | 585.48M 1.02% | 618.12M 1.89% | 623.22M 0.82% | 606.9M 1.47% |
| EBITDA Q2Q % growth | 231.62M 10.30% | 262.14M -38.35% | 257.69M -57.67% | 258.93M -68.24% | 243.63M 5.19% | 271.27M 3.48% | 272.75M 5.84% | 270.76M 4.57% |
| EBIT Q2Q % growth | 18.431M -25.08% | 42.606M -12.87% | 39.215M -3.41% | 37.154M -35.94% | 25.959M 40.84% | 48.756M 14.43% | 44.88M 14.45% | 46.206M 24.36% |
All data in USD
13 analysts have analysed CLVT and the average price target is 4.42 USD. This implies a price increase of 74.11% is expected in the next year compared to the current price of 2.54.
CLARIVATE PLC (CLVT) will report earnings on 2026-04-27.
The consensus EPS estimate for the next earnings of CLARIVATE PLC (CLVT) is 0.15 USD and the consensus revenue estimate is 579.57M USD.
The consensus rating for CLARIVATE PLC (CLVT) is 53.8462 / 100 . This indicates that analysts generally have a neutral outlook on the stock.